Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02315963
Recruitment Status : Recruiting
First Posted : December 12, 2014
Last Update Posted : August 15, 2018
Sponsor:
Information provided by (Responsible Party):
Cereneo AG

Brief Summary:
High motivation is a predictor for good therapy results in physical therapy [Grahn 2000]. The investigator want to show that it is possible to increase patients motivation for stroke rehabilitation by providing them objective performance feedback about the patients therapy progress.

Condition or disease Intervention/treatment Phase
Stroke Other: Performance Feedback Not Applicable

Detailed Description:

High motivation is a predictor for good therapy results in physical therapy [Grahn 2000]. Additional focus on motivation and rewards has fallen on the topic of stroke rehabilitation since it was shown in an animal model that the brain centers involved with motivation and rewards are crucial to motor learning [Hosp 2011].

The investigators goal is to target the overall motivation for therapy. During the guided therapy sessions the therapists will be the main motivators and the investigators do not want to interfere with that. But the amount of guided therapy sessions is often limited due to economical reason rather than therapeutic ones. Therefore patients are encouraged to do training on their own if possible and to be active during the patients stay in the rehabilitation clinic. The investigators target the patients motivation to train by themselves and be active but also the patients attitude towards the guided therapies. It is known that performance feedback can improve motivation [Harackiewicz 1979]. Therefore the investigators want to use the data about therapy progress to produce feedback for patients visualizing the patients progress and efforts during the patients stay in the clinic.

The investigators will compare patients who receive normal therapy to patients who receive normal therapy plus performance feedback regarding a variety of motivation measures.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 62 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation
Study Start Date : April 2016
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: No intervention group
Patients in stroke rehabilitation receiving standard therapy
Active Comparator: Intervention group
Patients in stroke rehabilitation receiving standard therapy plus performance feedback
Other: Performance Feedback
Performance Feedback regarding the patients efforts and accomplishments during the patients stay in the rehabilitation clinic, an expected average of 6 weeks. The data available about the patients progress will be analysed and processed to create a visual illustration shown to the patient on a daily bases.




Primary Outcome Measures :
  1. Motivation [ Time Frame: Weekly for the duration of the participants stay at the hospital an expected average of 6 weeks ]
    Weekly: Intrinsic Motivation Inventory Questionnaire

  2. Motivation [ Time Frame: After each therapy session for the duration of the participants stay at the hospital an expected average of 6 weeks ]
    Motivation rating of patients regarding the foregoing therapy session by therapists

  3. Motivation [ Time Frame: Continuous for the duration of the participants stay at the hospital an expected average of 6 weeks ]
    Time patient spends on self administered training

  4. Motivation [ Time Frame: Continuousfor the duration of the participants stay at the hospital an expected average of 6 weeks ]
    Amount of activities (walking, stair climbing) during free time


Secondary Outcome Measures :
  1. Clinical scores (e.g. Fugl-Meyer Score) [ Time Frame: When decided by therapists for the duration of the participants stay at the hospital an expected average of 6 weeks ]
    Standard quality assessments of the study site (rehabilitation clinic)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • First time Inpatient at the Cereneo rehabilitation clinic

Exclusion Criteria:

  • Rey-Figur Kopie <= 25 AND Rechnerisches Denken WIE <=5
  • Becks Depression Inventar (BDI) > 17
  • Major aphasia preventing understanding of study materials (according to the treating physician).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02315963


Locations
Layout table for location information
Switzerland
Cereneo, Center For Rehabilitation and Neurology Recruiting
Vitznau, Lucerne, Switzerland, 6354
Contact: Robinson Kundert, MSc (ETH)    +41 76 5089129    robinson.kundert@hest.ethz.ch   
Principal Investigator: Andreas Luft, Prof. MD         
Sponsors and Collaborators
Cereneo AG

Publications:
Layout table for additonal information
Responsible Party: Cereneo AG
ClinicalTrials.gov Identifier: NCT02315963     History of Changes
Other Study ID Numbers: KFSP Feedback Study
First Posted: December 12, 2014    Key Record Dates
Last Update Posted: August 15, 2018
Last Verified: June 2016

Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases